Drosophila Screening Identifies Dual Inhibition of MEK and AURKB as an Effective Therapy for Pancreatic Ductal Adenocarcinoma

被引：4

作者：

Sekiya, Sho ^{[1
,2
]}

Fukuda, Junki ^{[1
,2
]}

Yamamura, Ryodai ^{[1
]}

Ooshio, Takako ^{[1
]}

Satoh, Yusuke ^{[1
]}

Kosuge, Shinya ^{[1
,2
]}

Sato, Reo ^{[1
]}

Hatanaka, Kanako C. ^{[3
]}

Hatanaka, Yutaka ^{[3
,4
]}

Mitsuhashi, Tomoko ^{[5
]}

Nakamura, Toru ^{[2
]}

Matsuno, Yoshihiro ^{[5
]}

Hirano, Satoshi ^{[2
]}

Sonoshita, Masahiro ^{[1
,6
]}

机构：

[1] Hokkaido Univ, Inst Genet Med, Div Biomed Oncol, Sapporo 0600815, Japan

[2] Hokkaido Univ, Fac Med, Dept Gastroenterol Surg 2, Sapporo, Japan

[3] Hokkaido Univ Hosp, Ctr Dev Adv Diagnost, Sapporo, Japan

[4] Hokkaido Univ Hosp, Res Div Genome Compan Diagnost, Sapporo, Japan

[5] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Japan

[6] Hokkaido Univ, Global Stn Biosurfaces & Drug Discovery, Sapporo 0600812, Japan

来源：

CANCER RESEARCH | 2023年 / 83卷 / 16期

基金：

日本学术振兴会; 日本科学技术振兴机构;

关键词：

PHASE-1; DOSE-ESCALATION; AURORA-B; CANCER; KINASE; TRAMETINIB; COOPERATE; GEMCITABINE; PROGRESSION; EXPRESSION; KRAS(G12D);

D O I：

10.1158/0008-5472.CAN-22-3762

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Significant progress has been made in understanding the pathogenesis of pancreatic ductal adenocarcinoma (PDAC) by generating and using murine models. To accelerate drug discovery by identifying novel therapeutic targets on a systemic level, here we generated a Drosophila model mimicking the alterations), which is associated with the worst prognosis in patients. The '4-hit' flies displayed epithelial transformation and decreased survival. Comprehensive genetic screening of their entire kinome revealed kinases including MEK and AURKB as therapeutic targets. Consistently, a combination of the MEK

引用

页码：2704 / 2715

页数：12

共 50 条

[21] Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma
Capello, Michela
Lee, Minhee
Wang, Hong
Babel, Ingrid
Katz, Matthew H.
Fleming, Jason B.
Maitra, Anirban
Wang, Huamin
Tian, Weihua
Taguchi, Ayumu
Hanash, Samir M.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (08):
[22] Extracellular lumican augments cytotoxicity of chemotherapy in pancreatic ductal adenocarcinoma cells via autophagy inhibition
Li, X.
Roife, D.
Kang, Y.
Dai, B.
Pratt, M.
Fleming, J. B.
ONCOGENE, 2016, 35 (37) : 4881 - 4890
[23] A Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma
Collisson, Eric A.
Trejo, Christy L.
Silva, Jillian M.
Gu, Shenda
Korkola, James E.
Heiser, Laura M.
Charles, Roch-Philippe
Rabinovich, Brian A.
Hann, Byron
Dankort, David
Spellman, Paul T.
Phillips, Wayne A.
Gray, Joe W.
McMahon, Martin
CANCER DISCOVERY, 2012, 2 (08) : 685 - 693
[24] Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy
Soreide, Kjetil
Primavesi, Florian
Labori, Knut J.
Watson, Martin M.
Staettner, Stefan
EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2019, 51 (03): : 126 - 134
[25] Biomarker-Based Therapy in Pancreatic Ductal Adenocarcinoma: An Emerging Reality?
Krantz, Benjamin A.
O'Reilly, Eileen M.
CLINICAL CANCER RESEARCH, 2018, 24 (10) : 2241 - 2250
[26] SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma
Song, Xianzhou
Chen, Hui
Zhang, Chengwei
Yu, Yang
Chen, Zhongyuan
Liang, Han
Van Buren, George, II
McElhany, Amy L.
Fisher, William E.
Lonard, David M.
O'Malley, Bert W.
Wang, Jin
CANCER LETTERS, 2019, 442 : 310 - 319
[27] Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma
Subramani, Ramadevi
Lopez-Valdez, Rebecca
Salcido, Alyssa
Boopalan, Thiyagarajan
Arumugam, Arunkumar
Nandy, Sushmita
Lakshmanaswamy, Rajkumar
EXPERIMENTAL AND MOLECULAR MEDICINE, 2014, 46 : e117 - e117
[28] Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma
Cook, Natalie
Frese, Kristopher K.
Bapiro, Tashinga E.
Jacobetz, Michael A.
Gopinathan, Aarthi
Miller, Jodi L.
Rao, Sudhir S.
Demuth, Tim
Howat, William J.
Jodrell, Duncan I.
Tuveson, David A.
JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (03): : 437 - 444
[29] Patient Preferences for Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
Hamad, Ahmad
Crossnohere, Norah
Ejaz, Aslam
Tsung, Allan
Pawlik, Timothy M.
Sarna, Angela
Santry, Heena
Wills, Celia
Cloyd, Jordan M.
PANCREAS, 2022, 51 (06) : 657 - 662
[30] Evolution of Systemic Therapy in Metastatic Pancreatic Ductal Adenocarcinoma
Kamgar, Mandana
Chakrabarti, Sakti
Shreenivas, Aditya
George, Ben
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 30 (04) : 673 - 691

← 1 2 3 4 5 →